期刊文献+

ApoB/ApoA1比值与胰岛素抵抗的相关性研究 被引量:6

Study of association between ApoB/ApoA1 ratio and insulin resistance
下载PDF
导出
摘要 目的:探讨载脂蛋白B(ApoB)/载脂蛋白A1(ApoA1)比值与胰岛素抵抗(Insulin Resistance,IR)的关系。方法:纳入673例重庆地区成年人,测定体重、身高、血压、腰围、空腹血浆葡萄糖(Fastingplasma glucose,FPG)、空腹血清胰岛素(Fasting serum insulin,FINS)及血脂等,计算ApoB/ApoA1比值、体重指数(Bodymassindex,BMI)及胰岛素抵抗指数(Homa-IR)。根据ApoB/ApoA1的四分位值将人群分为4组,用Logistic回归分析ApoB/ApoA1值与IR的关系。结果:与非胰岛素抵抗(Non-insulinresistance)者相比,IR人群的年龄、BMI、收缩压、舒张压、FPG、FINS、TG、LDL-c水平及ApoB/ApoA1比值均显著增高,而HDL-c水平降低(P<0.05);随ApoB/ApoA1值增高,HomaIR值逐渐增高(P<0.001);ApoB/ApoA1值最高组(上四分位组)发生IR的风险是最低组(下四分位组)的2.586倍(P=0.001)。结论:ApoB/ApoA1比值与IR密切相关,ApoB/ApoA1比值增高是IR发生的重要标志。 Objective:To assess if the ratio of ApoB/ApoA1 is related to insulin resistance.Methods:673 adults living in Chongqing were enrolled.Weight,height,blood pressure,waist circumferences,fasting plasma glucose(FPG),fasting serum insulin(FINS)and lipids were measured.ApoB/ApoA1 ratio,BMI and insulin resistance index(Homa-IR)were calculated.Subjects were divided into four groups according to the quartiles of ApoB/ApoA1 ratio.Logistic regression was used to estimate the relation between ApoB/ApoA1 ratio and insulin resistance.Results:Compared with the non-insulin resistant group,the insulin resistant group is older and has on average greater mean values for BMI,systolic and diastolic blood pressure,fasting plasma glucose,triglycerides,LDL-cholesterol,and ApoB/ApoA1 ratio.In contrast,insulin resistant subjects has significantly lower HDL-cholesterol than insulin sensitive subjects(P〈0.05).Homeostasis model assessment increased significantly as ApoB/ApoA1 ratio increased(P〈0.001).Compared with the lowest quartile of ApoB/ApoA1 ratio,the highest quartile of ApoB/ApoA1 ratio is more likely to get IR,and the risk increased 2.586 times(P=0.001).Conclusion:ApoB/ApoA1 ratio is strongly associated with insulin resistance(IR),and a high ApoB/ApoA1 ratio is a valuable marker of IR.
出处 《重庆医科大学学报》 CAS CSCD 北大核心 2010年第4期575-578,共4页 Journal of Chongqing Medical University
基金 重庆市科委科研基金资助项目(编号:CSTC 2008BB5206)
关键词 ApoB/ApoA1比值 胰岛素抵抗 ApoB/ApoA1 ratio Insulin resistance
  • 相关文献

参考文献13

  • 1Py(o)r(a)l(a) M,Miettinen H,Halonen P,et al.Insulin resistance syn-drome predicts the risk of coronary heart disease and stroke in healthy middle-aged men:the 22-year follow-up results of the Helsinki Policemen Study[J].Arterioscler Thromb Vase Biol,2000,20(2):538-544.
  • 2Sierra-Johnson J,Romero-Corral A,Somers VK,et al.ApoB/ApoA-I ratio:an independent predictor of insulin resistance in US non-diabetic subjects[J].European Heart Journal,2007,28(21):2637-2643.
  • 3Matthews DR,Hosker JP,Rudenski AS,et al.Homeostasis model assessment:insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man[J].Diabetologia,1985,28(7):412-419.
  • 4Walldius G,Jungner I.The apoB/apoA-I ratio:a strong,new risk factor for cardiovascular disease and a target for lipid-lowering therapy-a review of the evidence[J].Journal of Internal Medicine,2006,259 (5):493-519.
  • 5Barter P J,Ballantyne C M,Carmena R,et al.ApoB versus cholesterol in estimating cardiovascular risk and in guiding therapy:report of the thirty-person/ten-country panel[J].J Intern Med,2006,259(3):247-258.
  • 6Talmud P J,Hawe E,Miller G J,et al.Nonfasting apolipoprotein B and triglyceride levels as a useful predictor of coronary heart disease risk in middle-aged UK men[J].Arterioscler Thromb Vase Biol,2002,22(11):1918-1923.
  • 7Walldius C,Jungner I,Holme I,et al.High apolipoprotein B,low apolipoprotein A-I,and improvement in the prediction of fatal myocardial infarction (AMORIS study):a prospective study[J].Lancet,2001,358 (9298):2026-2033.
  • 8Yusuf S,Hawken S,Ounpuu S,et al.Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the in-terheart study):case-control study[J].Lancet,2004,364(9438):937-952.
  • 9Sierra-Johnson J,Fisher R M,Romero-Corral A,et al.Concentration of apolipoprotein B is comparable with the apolipoprotein B/apolipo protein A-I ratio and better than routine clinical lipid measurements in predicting coronary heart disease mortality:findings from a multi-ethnic US population[J].Eur Heart J,2009,30(6):710-717.
  • 10陈玉熹,缪心军,蔡平平.载脂蛋白B与进展性脑梗死的相关性探讨[J].实用老年医学,2006,20(5):350-351. 被引量:5

二级参考文献16

  • 1脑卒中患者临床神经功能缺损程度评分标准(1995)[J].中华神经科杂志,1996,29(6):381-383. 被引量:15747
  • 2王聪霞,孙济川,田清海,丁抗宁,张进虎,岳天海.冠心病患者血清载脂蛋白AI、B_(100)与组织型纤溶酶原激活剂及其抑制物的相关性[J].中国循环杂志,1997,12(1):20-23. 被引量:12
  • 3Licata G,Tuttolomondo A,Sinagra D,et al.Diabetes mellitus and stroke[J].Ital Heart J,2002,3(5):471.
  • 4Gadre E,Lassen NA.Apoplexy with rapidly deteriorating symptoms-"stroke in progression" Hemodynamic and clinical aspects[J].Ugeskr-Laeger,1995,157(30):4234.
  • 5Lebovitz HE. Insulin resistance-a common link between type 2 diabetes and cardiovascular disease. Diabetes Obes Metab, 2006, 8 : 237 - 249.
  • 6Abdella NA, Mojiminiyi OA, Akanji AO, et al. Serum lipoprotein (a) concentration as a cardiovascular risk factor in Kuwaiti type 2 diabetic patients. J Diabetes Complications, 2001, 15:270 - 276.
  • 7Saely CH, Koch L, Schmid F, et al. Lipoprotein (a), type 2 diabetes and vascular risk in coronary patients. Eur J Clin Invest, 2006, 36:91 - 97.
  • 8Hernandez C, Chacon P, Garcia-Pascual L, et al. Differential influence of LDL cholesterol and triglycerides on lipoprotein(a) con- centrations in diabetic patients. Diabetes Care, 2001, 24:350-355.
  • 9Lars Lind. Vasodilation in resistance arteries is related to the apolipoprotein B/Al ratio in the elderly: the prospective investigation of the vasculature in uppsala seniors (PIVUS) study. Atherosclerosis, 2007, 190 : 378 - 384.
  • 10VanderSteeg WA, Boekholdt SM, Stein EA, et al. Role of the apolipoprotein B-apolipoprotein A-l ratio in cardiovascular risk assessment: a case-control analysis in EPIC-Norfolk. Ann Intern Med, 2007, 146:640 - 648.

共引文献10

同被引文献44

  • 1Chiara Lazzeri,Serafina Valente,Marco Chiostri,Maria Grazia D'Alfonso,Gian Franco Gensini.Clinical significance of glycated hemoglobin in the acute phase of ST elevation myocardial infarction[J].World Journal of Cardiology,2014,6(4):140-147. 被引量:2
  • 2Walldius G,Jungner J. Is there a better marker of cardiovascular risk than LDL cholesterol? Apolipoproteins B and A-I-New risk factors and targets for therapy[J]. Nutr Metab Cardiovasc Dis, 2007,17(8):565-571.
  • 3Bruno G, Merletti F, Biggeri A, et al. Effect of age on the associa- tion of non-high-density lipoprotein cholesterol and apolipopro- teinB with cardiovascular mortality in a Mediterranean population with type 2 diabetes: the casale monferrato study[J]. Diabetolo- gia,2006,49(5) :937-944.
  • 4Sierra-Johnson J, Romero-Corral A, Somers VK, et al. ApoB/ApoA-I ratio: an independent predictor of insulin resistance in US non-diabetic subjeets[J]. Eur Heart J,2007,28(21) :2637-2643.
  • 5FRANKS S. Polycystic ovary syndrome[J].New England Journal of Medicine,1995,(21):853-861.
  • 6FARAJ M,MESSIER L,BASTARD J P. Apolipoprotein B:a predictor of inflammatory status in postmenopausal overweight and obese women[J].Diabetologia,2006,(07):1637-1646.
  • 7SIERRA JOHNSON J,ROMERO CORRAL A,SOMERS V K. ApoB/apoA-Ⅰ ratio:an independent predictor of insulin resistance in US non-diabetic subjects[J].European Heart Journal,2007,(21):2637-2643.
  • 8LAM P M,MA R C,CHEUNG L P. Polycystic ovarian syndrome in Hong Kong Chinese women:patient characteristics and diagnostic criteria[J].Hong Kong Medical Journal,2005,(05):336-341.
  • 9LEGRO R S,BLANCHE P,KRAUSS R M. Alterations in low-density lipoprotein and high-density lipoprotein subclasses among Hispanic women with polycystic ovary syndrome:influence of insulin and genetic factors[J].Fertility and Sterility,1999,(06):990-995.
  • 10VALKENBURG O,STEEGERS THEUNISSEN R P,SMEDTS H P. A more atherogenic serum lipoprotein profile is present in women with polycystic ovary syndrome:a case-control study[J].Journal of Clinical Endocrinology and Metabolism,2008,(02):470-476.

引证文献6

二级引证文献18

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部